臨牀消化器内科 Vol.28 No.4(3)


特集名 NASH ― 病態と治療
題名 NAFLD/NASHの診断基準と問題点
発刊年月 2013年 04月
著者 川中 美和 川崎医科大学総合内科学2/川崎医科大学附属川崎病院
著者 山田 剛太郎 川崎医科大学総合内科学2/川崎医科大学附属川崎病院
【 要旨 】 非アルコール性脂肪性肝疾患(NAFLD)のなかには肝硬変へと進展していく非アルコール性脂肪肝炎(NASH)が2〜3割存在するといわれているが,未だ不明な点も多く,確定診断は肝生検である.1日20g以下の飲酒歴で,ウイルス性,自己免疫性,代謝性,薬物性肝障害などの慢性肝疾患を否定して行う除外診断である.確定診断は肝生検であり,肝組織で中心静脈周囲の大〜中滴性脂肪の存在,肝細胞風船様変性,炎症細胞浸潤,炎症細胞,中心静脈周囲や肝細胞周囲の線維化を伴う場合,NASHと診断する.NASHの診断は組織像が典型例では容易であるが,肝細胞風船様変性が典型的ではない場合,診断に苦悩する.
Theme NASH -- Pathogenesis and Treatment
Title Diagnostic Criteria for NAFLD/NASH
Author Miwa Kawanaka Department of General Internal Medicine 2, Kawasaki Hospital, Kawasaki Medical School
Author Gotaro Yamada Department of General Internal Medicine 2, Kawasaki Hospital, Kawasaki Medical School
[ Summary ] Nonalcoholic fatty liver disease (NAFLD) includes the category of nonalcoholic fatty liver (NAFL) conditions. These are generally mild, nonalcoholic steatohepatitis (NASH) which progresses to cirrhosis, liver failure and liver cancer. The diagnosis of NAFLD is based on the following criteria, (1) intake of less than 20 g of ethanol per day, or (2) appropriate exclusion of HBV, HCV, autoimmune liver disease, drug induced liver injury or metabolic liver disorders. Liver biopsy is the most reliable approach to identify the presence of steatohepatitis and fibrosis in patients with NAFLD. NAFL is indicated by the presence of hepatic steatosis with no evidence of hepatocyte injury (ballooning). NASH is indicated by the presence of heptic steatosis and inflammation with ballooning with or without fibrosis. It is easy to diagnose typical NASH, histologically. However, some patients with mild stage NASH or with burn-out NASH are still difficult to accurately diagnose.
戻る